We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 82.50 | 80.00 | 85.00 | 82.50 | 82.50 | 82.50 | 10,130 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Computers | 1.03M | -2.92M | -0.2188 | -3.77 | 11M |
Date | Subject | Author | Discuss |
---|---|---|---|
21/6/2021 23:56 | It is a little mystery why that release suddenly disappeared from the website. Maybe we will find out one day. Still, Bleepa looks really good, I like it and can quite clearly see the urgent need for such product to be rolled out to assist in the massive mountain of backlog self inflicted wound at the NHS. An institution we were meant to protect and save is in danger of collapsing within. Remains to be seen if Tom can pull off the deal of the century but I remain optimistic that if we continue to see adoption it could lead to a snowball effect. If covid slowed progress then it may have left an ideal situation for Bleepa to now thrive. 1p share price is reflective of this situation and at this level there should be some Fomo too I hope. | petekand | |
21/6/2021 17:13 | Cash burn in 12months £3.5million? Sarted with0.7mill raised 5mill, balance £2.2mill, LR2 will correct if wrong. | hulk2004 | |
21/6/2021 17:07 | You cannot go on £120k banked in June and extrapolate for year, company would have indicated that this rate of income would continue if so. Results very poor and cash burn high, placing will be before year is out but agree IQAI revenues stated are poor as well, so a lot to do there to. | hulk2004 | |
21/6/2021 15:30 | Trevor, FDBK banked £120k in the first 8 days of the current financial year. "The Company has already invoiced £0.12 million of revenue to be recognised during the current financial year in accordance with the Company's accounting policies and the Directors expect revenues to grow as sales of Bleepa increase during the rest of the financial year." If they do similar throughout year then 365 days / 8 x £120k = £5.475 mil for the year. Let's be cautious and say they only get £120k every 20 days then 365 / 20 x £120k = £2.19 mil for the year. Add on expected TexRAD income and the yearly revenue will be around £2.47 mil. Almost ten times the revenue currently achieved by IQAI. That will cover expenses I believe. Now IQAI had £255,314 revenue for last financial year and admin expenses of £933,462. Group loss of £717,534 after tax. Where are your sales / contracts 'meat'? LA County hospital isn't going to cut it, is it? Especially when you don't even indicate what kind of a bankable sum you will get for this, your one and only contract this year. | lr2 | |
21/6/2021 14:19 | 8050 New 8051 Old but worth listening to again. Interesting listening to comments about AI. Didn't they very recently link to an AI article? Thanks again! Potential inclusion in the HealthTech 50 but no contract announced. Notice they still had Feedback headquarters as Cambridge not London as it is now. | ged5 | |
21/6/2021 13:43 | Almost new. 3 days old but I haven't seen it mentioned here. Tom starts talking at 02:15. Lasts about 10 mins. | lr2 | |
21/6/2021 13:37 | I think this is new. | lr2 | |
18/6/2021 23:28 | Nice find LR2. Just hope the word gets around the hospitals. | digger2779 | |
18/6/2021 12:08 | I didn’t need a smartphone untill I got one! | ducatiman | |
18/6/2021 11:30 | I admit to having spoken to only one radiologist about Bleepa. She was extremely interested in Bleepa and considered it to be of value. The last time I spoke to her she was going to find out more. I've no idea if she has or not but her reaction indicated that what was in place wasn't sufficient. From what I read from Aunt Minnie and other radiology reports there is a need for improvements which might help rectify the big shortage of radiologists. | ged5 | |
18/6/2021 10:34 | Interesting Ged5 but all the potential users are already going about their day-jobs without a deficit on communications (I am in frequent contact with radiology departments of hospitals). From my research, the presumption of need originates only from Feedback, i.e not real. Real need would surely be reflected by commercial interest after all this time? Call a couple of radiology departments in hospitals and find our for yourself | ydderf | |
18/6/2021 09:49 | "Clinical users at hospitals with a Bleepa contract will be able to download the app on both Apple App Store and Google Play. The CE marked medical device is the only regulated platform on the NHSX Clinical Communications Framework that allows users to share images at a standard approved for clinical use." | ged5 | |
17/6/2021 13:31 | Yump's first law states that when not many people are interested in a share and there is a frustrating lack of progress, leading to people looking for hints of progress, then its probably the best time to buy. Yump's second law states that yump's first law only applies, when you've done your analysis of features and benefits of the product and found out that it has no significant direct competitors. But who cares anyway about anyone's apparent "cleverness" on here. | yump | |
17/6/2021 12:33 | If Occam's razor is applied, the most likely explanation is that it was considered market sensitive and taken down, but in this case there would have been an RNS by now, or it was wrong and therefore misleading and taken down......either way, the share price is eloquent ydderF's law states that when bulletin boards are focused on minutiae like how many shares were traded at what price (often a few hundred quids worth in this share) and what obscure mention it got on some obscure third party website, it is not a healthy development...... | ydderf | |
17/6/2021 12:01 | Has anyone contacted the company for an explanation? | ducatiman | |
16/6/2021 22:23 | copied for you : Bleepa contract expands to Fairfield General Hospital 14/06/21 Bleepa Uncategorised We are pleased to announce the expansion of Bleepa into the Fairfield General Hospital! Bleepa is our flagship clinical communications platform. Supporting collaboration and communication Fairfield General Hospital is part of the Pennine Acute Hospital Trust and Northern Care Alliance Group. Initially, Bleepa was contracted for the Respiratory inpatient referral pathway at the Royal Oldham Hospital and has since been expanded across 10 specialties. As a result, The Trust wants to broaden the use of Bleepa as part of its strategy for greater collaboration and communication amongst clinical staff. Therefore, Fairfield General Hospital will now introduce Bleepa as the referral management tool for its Gastrointestinal and General Surgery specialties. Thus, Fairfield will have access to Bleepa’s unique and extensive features. These include intra-Trust referral pathways, image annotation, discussion capabilities, virtual multi-disciplinary meetings, and Photo-capture. All of which will create a leading clinician experience for on-the-go care delivery. “As our relationship continues to strengthen with the Pennine Acute Hospital Trust, we are delighted to see Bleepa being rolled out to an additional hospital, as well as expansion of its use within the Royal Oldham Hospital. Bleepa is the only CE-certified clinical imaging communication tool that can deliver the necessary workflow support at the scale required, with unique digital patient file access, annotation, and flexibility to enable a swift, smooth, and efficient digital referral tool for clinicians across the hospital. As Bleepa’s reputation as the clinicians’ tool of choice gains momentum, we continually look at how we can enhance its features to streamline the patient pathway and provide the digital support our clinicians need.” Dr Tom Oakley, CEO of Feedback Medical. About Fairfield General Hospital Fairfield General Hospital is the third-largest hospital run by the Trust. It is located two miles from the centre of Bury and 10.5 miles north of Manchester. Currently, it is the only remaining hospital in Bury and is one of three primary stroke units in Greater Manchester. It is also the main site for elective surgery in the North Manchester area. Additionally, the Trust has invested £2m to improve facilities in the hospital’s accident and emergency department. The improvements include a new, dedicated Children’s A&E department, which was launched in Summer 2014. | leoboy | |
16/6/2021 20:11 | It was definitely there Pete, I saw it too, we are not going mad, lol. | ducatiman | |
16/6/2021 18:57 | Yes, does appear to have disappeared. If I go to the news section, I can find all the recent items but just not the one in question. | petekand | |
16/6/2021 17:57 | But if you go to their website Ged and search Bleepa “no results found”. | ducatiman |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions